MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$21,085K
EPS
-$16.72
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
10,960
General and administrative
11,328
Long-lived asset impairment
0
Total operating expenses
22,288
Loss from operations
-22,288
Interest income
1,239
Interest expense
32
Other expense, net
-4
Net loss
-21,085
Net loss attributable to common stockholders
-21,085
Basic EPS
-16.72
Diluted EPS
-16.72
Basic Average Shares
1,260,772
Diluted Average Shares
1,260,772
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$21,085K Net loss-$21,085K Interest income$1,239K Loss from operations-$22,288K Interest expense$32K Other expense, net-$4K Total operatingexpenses$22,288K General andadministrative$11,328K Research and development$10,960K

Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics, Inc. (SNSE)